Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation
Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction t...
Gespeichert in:
Veröffentlicht in: | ACS chemical neuroscience 2016-11, Vol.7 (11), p.1531-1542 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1542 |
---|---|
container_issue | 11 |
container_start_page | 1531 |
container_title | ACS chemical neuroscience |
container_volume | 7 |
creator | Vonder Haar, Cole Lam, Frederick C.W Adams, Wendy K Riparip, Lara-Kirstie Kaur, Sukhbir Muthukrishna, Michael Rosi, Susanna Winstanley, Catharine A |
description | Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury. |
doi_str_mv | 10.1021/acschemneuro.6b00166 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9487719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1847884637</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</originalsourceid><addsrcrecordid>eNp9UU2P0zAQtRCIXQr_ACEfuWSxU-frglQCC5UqQLCcrUkyaVzFdrCdRf15_DMctazKhZNHM--9eeNHyEvObjhL-RtofTugNjg7e5M3jPE8f0SueSXKpODV-vFFfUWeeX9gLK9YmT8lV2mRpZkQxTX5feusCTDSOwezhqBa-s6BMnRrDrM70lh9g-BpDbNHT3fW7JMd-KDMnm71BMppNHG-MPQ0jx5pHQWdjYoDBLpxSN-rvkcXYQrG8Ui_o_EqqHukwdKvAzgNrQ0DOphwjgY8BdPRjfe2VRCwo79UGGg9RKPR3eflXmX6EfRi15rn5EkPce-L87siP24_3NWfkt2Xj9t6s0tAiCokkGcouqxqBAPBGgFtV6Yii900x57xruuyPOW8hI5VBbKmzxrsI6IR_dJdr8jbk-40Nxq7Nt7jYJSTUxrcUVpQ8t-JUYPc23sZQyiWEFbk9VnA2Z8z-iC18i2OIxi0s5e8FEVZinxdRKg4QVtnvXfYP6zhTC7py8v05Tn9SHt1afGB9DfuCGAnQKTLg52diT_2f80_77fG0Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1847884637</pqid></control><display><type>article</type><title>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Vonder Haar, Cole ; Lam, Frederick C.W ; Adams, Wendy K ; Riparip, Lara-Kirstie ; Kaur, Sukhbir ; Muthukrishna, Michael ; Rosi, Susanna ; Winstanley, Catharine A</creator><creatorcontrib>Vonder Haar, Cole ; Lam, Frederick C.W ; Adams, Wendy K ; Riparip, Lara-Kirstie ; Kaur, Sukhbir ; Muthukrishna, Michael ; Rosi, Susanna ; Winstanley, Catharine A</creatorcontrib><description>Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.</description><identifier>ISSN: 1948-7193</identifier><identifier>EISSN: 1948-7193</identifier><identifier>DOI: 10.1021/acschemneuro.6b00166</identifier><identifier>PMID: 27525447</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acute Disease ; Adrenergic Uptake Inhibitors - pharmacology ; Amantadine - pharmacology ; Amphetamine - pharmacology ; Animals ; Atomoxetine Hydrochloride - pharmacology ; Brain Injuries, Traumatic - complications ; Brain Injuries, Traumatic - drug therapy ; Brain Injuries, Traumatic - physiopathology ; Brain Injuries, Traumatic - psychology ; Central Nervous System Stimulants - pharmacology ; Chronic Disease ; Disease Models, Animal ; Disease Progression ; Disruptive, Impulse Control, and Conduct Disorders - drug therapy ; Disruptive, Impulse Control, and Conduct Disorders - etiology ; Disruptive, Impulse Control, and Conduct Disorders - pathology ; Disruptive, Impulse Control, and Conduct Disorders - physiopathology ; Dopamine Agents - pharmacology ; Frontal Lobe - drug effects ; Frontal Lobe - immunology ; Frontal Lobe - injuries ; Frontal Lobe - pathology ; Male ; Motor Activity - drug effects ; Motor Activity - physiology ; Neuroimmunomodulation - drug effects ; Neuroimmunomodulation - physiology ; Rats, Long-Evans ; Severity of Illness Index</subject><ispartof>ACS chemical neuroscience, 2016-11, Vol.7 (11), p.1531-1542</ispartof><rights>Copyright © 2016 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</citedby><cites>FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acschemneuro.6b00166$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acschemneuro.6b00166$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27525447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vonder Haar, Cole</creatorcontrib><creatorcontrib>Lam, Frederick C.W</creatorcontrib><creatorcontrib>Adams, Wendy K</creatorcontrib><creatorcontrib>Riparip, Lara-Kirstie</creatorcontrib><creatorcontrib>Kaur, Sukhbir</creatorcontrib><creatorcontrib>Muthukrishna, Michael</creatorcontrib><creatorcontrib>Rosi, Susanna</creatorcontrib><creatorcontrib>Winstanley, Catharine A</creatorcontrib><title>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</title><title>ACS chemical neuroscience</title><addtitle>ACS Chem. Neurosci</addtitle><description>Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.</description><subject>Acute Disease</subject><subject>Adrenergic Uptake Inhibitors - pharmacology</subject><subject>Amantadine - pharmacology</subject><subject>Amphetamine - pharmacology</subject><subject>Animals</subject><subject>Atomoxetine Hydrochloride - pharmacology</subject><subject>Brain Injuries, Traumatic - complications</subject><subject>Brain Injuries, Traumatic - drug therapy</subject><subject>Brain Injuries, Traumatic - physiopathology</subject><subject>Brain Injuries, Traumatic - psychology</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Chronic Disease</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - drug therapy</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - etiology</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - pathology</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - physiopathology</subject><subject>Dopamine Agents - pharmacology</subject><subject>Frontal Lobe - drug effects</subject><subject>Frontal Lobe - immunology</subject><subject>Frontal Lobe - injuries</subject><subject>Frontal Lobe - pathology</subject><subject>Male</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>Neuroimmunomodulation - drug effects</subject><subject>Neuroimmunomodulation - physiology</subject><subject>Rats, Long-Evans</subject><subject>Severity of Illness Index</subject><issn>1948-7193</issn><issn>1948-7193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU2P0zAQtRCIXQr_ACEfuWSxU-frglQCC5UqQLCcrUkyaVzFdrCdRf15_DMctazKhZNHM--9eeNHyEvObjhL-RtofTugNjg7e5M3jPE8f0SueSXKpODV-vFFfUWeeX9gLK9YmT8lV2mRpZkQxTX5feusCTDSOwezhqBa-s6BMnRrDrM70lh9g-BpDbNHT3fW7JMd-KDMnm71BMppNHG-MPQ0jx5pHQWdjYoDBLpxSN-rvkcXYQrG8Ui_o_EqqHukwdKvAzgNrQ0DOphwjgY8BdPRjfe2VRCwo79UGGg9RKPR3eflXmX6EfRi15rn5EkPce-L87siP24_3NWfkt2Xj9t6s0tAiCokkGcouqxqBAPBGgFtV6Yii900x57xruuyPOW8hI5VBbKmzxrsI6IR_dJdr8jbk-40Nxq7Nt7jYJSTUxrcUVpQ8t-JUYPc23sZQyiWEFbk9VnA2Z8z-iC18i2OIxi0s5e8FEVZinxdRKg4QVtnvXfYP6zhTC7py8v05Tn9SHt1afGB9DfuCGAnQKTLg52diT_2f80_77fG0Q</recordid><startdate>20161116</startdate><enddate>20161116</enddate><creator>Vonder Haar, Cole</creator><creator>Lam, Frederick C.W</creator><creator>Adams, Wendy K</creator><creator>Riparip, Lara-Kirstie</creator><creator>Kaur, Sukhbir</creator><creator>Muthukrishna, Michael</creator><creator>Rosi, Susanna</creator><creator>Winstanley, Catharine A</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161116</creationdate><title>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</title><author>Vonder Haar, Cole ; Lam, Frederick C.W ; Adams, Wendy K ; Riparip, Lara-Kirstie ; Kaur, Sukhbir ; Muthukrishna, Michael ; Rosi, Susanna ; Winstanley, Catharine A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute Disease</topic><topic>Adrenergic Uptake Inhibitors - pharmacology</topic><topic>Amantadine - pharmacology</topic><topic>Amphetamine - pharmacology</topic><topic>Animals</topic><topic>Atomoxetine Hydrochloride - pharmacology</topic><topic>Brain Injuries, Traumatic - complications</topic><topic>Brain Injuries, Traumatic - drug therapy</topic><topic>Brain Injuries, Traumatic - physiopathology</topic><topic>Brain Injuries, Traumatic - psychology</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Chronic Disease</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - drug therapy</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - etiology</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - pathology</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - physiopathology</topic><topic>Dopamine Agents - pharmacology</topic><topic>Frontal Lobe - drug effects</topic><topic>Frontal Lobe - immunology</topic><topic>Frontal Lobe - injuries</topic><topic>Frontal Lobe - pathology</topic><topic>Male</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>Neuroimmunomodulation - drug effects</topic><topic>Neuroimmunomodulation - physiology</topic><topic>Rats, Long-Evans</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vonder Haar, Cole</creatorcontrib><creatorcontrib>Lam, Frederick C.W</creatorcontrib><creatorcontrib>Adams, Wendy K</creatorcontrib><creatorcontrib>Riparip, Lara-Kirstie</creatorcontrib><creatorcontrib>Kaur, Sukhbir</creatorcontrib><creatorcontrib>Muthukrishna, Michael</creatorcontrib><creatorcontrib>Rosi, Susanna</creatorcontrib><creatorcontrib>Winstanley, Catharine A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS chemical neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vonder Haar, Cole</au><au>Lam, Frederick C.W</au><au>Adams, Wendy K</au><au>Riparip, Lara-Kirstie</au><au>Kaur, Sukhbir</au><au>Muthukrishna, Michael</au><au>Rosi, Susanna</au><au>Winstanley, Catharine A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</atitle><jtitle>ACS chemical neuroscience</jtitle><addtitle>ACS Chem. Neurosci</addtitle><date>2016-11-16</date><risdate>2016</risdate><volume>7</volume><issue>11</issue><spage>1531</spage><epage>1542</epage><pages>1531-1542</pages><issn>1948-7193</issn><eissn>1948-7193</eissn><abstract>Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27525447</pmid><doi>10.1021/acschemneuro.6b00166</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1948-7193 |
ispartof | ACS chemical neuroscience, 2016-11, Vol.7 (11), p.1531-1542 |
issn | 1948-7193 1948-7193 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9487719 |
source | MEDLINE; American Chemical Society Journals |
subjects | Acute Disease Adrenergic Uptake Inhibitors - pharmacology Amantadine - pharmacology Amphetamine - pharmacology Animals Atomoxetine Hydrochloride - pharmacology Brain Injuries, Traumatic - complications Brain Injuries, Traumatic - drug therapy Brain Injuries, Traumatic - physiopathology Brain Injuries, Traumatic - psychology Central Nervous System Stimulants - pharmacology Chronic Disease Disease Models, Animal Disease Progression Disruptive, Impulse Control, and Conduct Disorders - drug therapy Disruptive, Impulse Control, and Conduct Disorders - etiology Disruptive, Impulse Control, and Conduct Disorders - pathology Disruptive, Impulse Control, and Conduct Disorders - physiopathology Dopamine Agents - pharmacology Frontal Lobe - drug effects Frontal Lobe - immunology Frontal Lobe - injuries Frontal Lobe - pathology Male Motor Activity - drug effects Motor Activity - physiology Neuroimmunomodulation - drug effects Neuroimmunomodulation - physiology Rats, Long-Evans Severity of Illness Index |
title | Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A00%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frontal%20Traumatic%20Brain%20Injury%20in%20Rats%20Causes%20Long-Lasting%20Impairments%20in%20Impulse%20Control%20That%20Are%20Differentially%20Sensitive%20to%20Pharmacotherapeutics%20and%20Associated%20with%20Chronic%20Neuroinflammation&rft.jtitle=ACS%20chemical%20neuroscience&rft.au=Vonder%20Haar,%20Cole&rft.date=2016-11-16&rft.volume=7&rft.issue=11&rft.spage=1531&rft.epage=1542&rft.pages=1531-1542&rft.issn=1948-7193&rft.eissn=1948-7193&rft_id=info:doi/10.1021/acschemneuro.6b00166&rft_dat=%3Cproquest_pubme%3E1847884637%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1847884637&rft_id=info:pmid/27525447&rfr_iscdi=true |